Document:

Form of Common Stock Warrant of Solazyme, Inc

 Exhibit 4.3 
 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”), AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 

 

			
	No. WC – 000_	  	 Warrant to Purchase up to
 [    ] Shares of Common Stock
 (subject to adjustment pursuant to
Section 12)

 WARRANT TO PURCHASE COMMON STOCK 

of 

SOLAZYME, INC. 
 Void after [    ] 
 This certifies that, for value received,
[    ] or its assigns (“Holder”) is entitled, subject to the terms set forth below, to purchase from Solazyme, Inc. (the “Company”), a Delaware corporation, up to [    ] shares of the
Common Stock of the Company, as constituted on the date hereof (the “Warrant Issue Date”), upon surrender hereof, at the principal office of the Company referred to below, and simultaneous payment therefor in lawful money of the United
States or otherwise as hereinafter provided, of the Exercise Price as set forth in Section 2 below. The number, character and Exercise Price of such shares of Common Stock are subject to adjustment as provided below. The term
“Warrant” as used herein shall include this Warrant, and any warrants delivered in substitution or exchange therefor as provided herein. 
 1. Term of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part, at any time, or from time to time, commencing on
[    ] and ending at the earliest of (a) 5:00 p.m. Pacific time on [    ], or (b) immediately prior to the closing of a firm commitment underwritten public offering pursuant to an effective
registration statement under the Securities Act of 1933, as amended (the “Act”), covering the offer and sale of equity securities of the Company to the public (the “IPO”). The first to occur among clauses
(a) or (b) in the preceding sentence shall be the expiration date (the “Expiration Date”) of this Warrant and the right of a Holder to exercise this Warrant shall be terminated on such Expiration Date. The Company will give the
Holder notice specifying the date of an IPO by overnight delivery at least five (5) days prior to the date of the scheduled occurrence thereof. 

 2. Exercise Price. The Exercise Price at which this Warrant may be exercised shall be
[    ] per share of Common Stock, as adjusted from time to time pursuant to Section 12 hereof. 
 3.
Exercise of Warrant. 
 (a) The purchase rights represented by this Warrant are exercisable by the Holder in whole or in
part, at any time, or from time to time, during the term hereof as described in Section 1 above, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly completed and executed on behalf of the Holder, at the principal
office of the Company (or such other office or agency of the Company as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company), upon payment (i) in cash or by check acceptable to
the Company, (ii) by cancellation by the Holder of indebtedness or other obligations of the Company to the Holder, or (iii) by a combination of (i) and (ii), of the purchase price of the shares to be purchased. 

(b) This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for
exercise as provided above, and the person or persons entitled to receive the shares of Common Stock issuable upon such exercise shall be treated for all purposes as the holder of record of such shares as of the close of business on such date. As
promptly as practicable on or after such date and in any event within forty-five (45) days thereafter, the Company, at its expense, shall issue and deliver to the person or persons entitled to receive the same a certificate or certificates for
the number of shares issuable upon such exercise. In the event that this Warrant is exercised in part, the Company at its expense, will execute and deliver a new Warrant of like tenor exercisable for the number of shares for which this Warrant may
then be exercised. 
 4. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant and the number of shares of Common Stock shall be rounded down to the nearest whole share. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company shall make a
cash payment equal to the Exercise Price multiplied by such fraction. 
 5. Replacement of Warrant. On receipt of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the
Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 

6. Rights of Stockholders. The Holder shall not be entitled to vote or receive dividends or be deemed the holder of Common Stock
or any other securities of the Company that may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the Holder, as such, any of the rights of a stockholder of the Company or
any right to vote for the election of 

  
 - 2 -

 
directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock,
reclassification of stock, change of par value, or change of stock to no par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant
shall have been exercised as provided herein. 
 7. Transfer of Warrant. 

(a) Warrant Register. The Company will maintain a register (the “Warrant Register”) containing the names and addresses of
the Holder or Holders. Any Holder of this Warrant or any portion thereof may change his or her address as shown on the Warrant Register by written notice to the Company requesting such change. Any notice or written communication required or
permitted to be given to the Holder may be delivered or given by mail to such Holder as shown on the Warrant Register and at the address shown on the Warrant Register. Until this Warrant is transferred on the Warrant Register of the Company, the
Company may treat the Holder as shown on the Warrant Register as the absolute owner of this Warrant for all purposes, notwithstanding any notice to the contrary. 
 (b) Warrant Agent. The Company may, by written notice to the Holder, appoint an agent for the purpose of maintaining the Warrant Register referred to in Section 7(a) above, issuing the Common
Stock or other securities then issuable upon the exercise of this Warrant, exchanging this Warrant, replacing this Warrant, or any or all of the foregoing. Thereafter, any such registration, issuance, exchange, or replacement, as the case may be,
shall be made at the office of such agent. 
 (c) Transferability and Non-negotiability of Warrant. This Warrant or the
Shares of Common Stock issued upon exercise hereof may not be transferred or assigned in whole or in part without prior compliance with all applicable federal and state securities laws by the transferor and the transferee (including the delivery of
investment representation and/or opinion letters reasonably satisfactory to the Company, if such are requested by the Company). Subject to the provisions of this Warrant with respect to compliance with the Securities Act of 1933, as amended (the
“Act”), and upon notice to the Company of the portion of this Warrant being transferred setting forth the name, address and taxpayer identification number of the transferee, title to this Warrant may be transferred by endorsement (by the
Holder executing the Assignment Form annexed hereto) and delivery in the same manner as a negotiable instrument transferable by endorsement and delivery. Notwithstanding the foregoing, under no circumstances shall the Holder transfer all or any part
of this Warrant or the Common Stock issuable upon exercise of this Warrant to any direct or indirect competitor of the Company. The terms and conditions of this Warrant shall inure to the benefit of, and be binding upon, the Company and the holders
hereof and their respective permitted successors and assigns. 
 (d) Exchange of Warrant upon a Transfer. On surrender of
this Warrant for exchange, properly endorsed on the Assignment Form and subject to the provisions of this Warrant with respect to compliance with the Act and with the limitations on 

  
 - 3 -

 
assignments and transfers contained in this Section 7, the Company at its expense shall issue to or on the order of the Holder a new warrant or warrants of like tenor, in the name of the
Holder or as the Holder (on payment by the Holder of any applicable transfer taxes) may direct, for the number of shares issuable upon exercise hereof. 
 (e) Compliance with Securities Laws. 
 (i) The Holder of
this Warrant, by acceptance hereof, acknowledges that this Warrant and the shares of Common Stock to be issued upon exercise hereof are being acquired solely for the Holder’s own account and not as a nominee for any other party, and for
investment, and that the Holder will not offer, sell or otherwise dispose of this Warrant or any shares of Common Stock to be issued upon exercise hereof except under circumstances that will not result in a violation of the Act or any state
securities laws. Upon exercise of this Warrant, the Holder shall, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the shares of Common Stock so purchased are being acquired solely for the Holder’s
own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale in violation of the Act. 
 (ii) This Warrant and all shares of Common Stock issued upon exercise hereof shall be stamped or imprinted with a legend in substantially the following form (in addition to any legend required by state
securities laws): 
 THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. SUCH SECURITIES AND ANY SECURITIES ISSUED HEREUNDER OR THEREUNDER MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR
AN EXEMPTION THEREFROM UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS. 
 8. [Reserved] 

9. Authorization of Stock. The Company covenants that during the term this Warrant is exercisable, the Company will have
authorized and unissued Common Stock of a sufficient number to provide for the issuance of Common Stock upon the exercise of this Warrant and, from time to time, will take all steps necessary to amend its Certificate of Incorporation (the
“Certificate”) to provide sufficient reserves of shares of Common Stock issuable upon exercise of the Warrant. The Company agrees that its issuance of this Warrant shall constitute full authority to its officers who are charged with the
duty of executing stock certificates to execute and issue the necessary certificates for shares of Common Stock upon the exercise of this Warrant. 

  
 - 4 -

 10. Notices. 
 (a) Whenever the Exercise Price or number of shares purchasable hereunder shall be adjusted pursuant to Section 12 hereof, the Company shall issue a certificate signed by its Chief Financial Officer
setting forth, in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Exercise Price and number of shares purchasable hereunder after giving effect to such
adjustment, and shall cause a copy of such certificate to be mailed (by first-class mail, postage prepaid) to the Holder of this Warrant. 
 (b) in case: 
 (i) The Company shall take a record of the holders
of its Common Stock (or other stock or securities at the time receivable upon the exercise of this Warrant) for the purpose of entitling them to receive any dividend or other distribution, or any right to subscribe for or purchase any shares of
stock of any class or any other securities, or to receive any other right, or 
 (ii) of any capital
reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation or merger of the Company with or into another corporation, or any conveyance of all or substantially all of the assets of the Company to
another corporation, or 
 (iii) of any voluntary dissolution, liquidation or winding-up of the Company,

 then, and in each such case, the Company will mail or cause to be mailed to the Holder or Holders a notice specifying, as the case may be,
(A) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character of such dividend, distribution or right, or (B) the date on which such reorganization,
reclassification, consolidation, merger, conveyance, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such stock or securities at the time receivable
upon the exercise of this Warrant) shall be entitled to exchange their shares of Common Stock (or such other stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger,
conveyance, dissolution, liquidation or winding-up. Such notice shall be mailed by overnight delivery at least ten (10) days prior to the date therein specified. 
 (c) All such notices, advices and communications shall be deemed to have been received (i) in the case of personal delivery, on the date of such delivery and (ii) in the case of mailing, on the
next business day following the date of such mailing by overnight delivery. 

  
 - 5 -

 11. Amendments. 

(a) Any term of this Warrant may be amended with the written consent of the Company and the Holder. 

(b) No waivers of, or exceptions to, any term, condition or provision of this Warrant, in any one or more instances, shall be deemed to
be, or construed as, a further or continuing waiver of any such term, condition or provision. 
 12. Adjustments. The
Exercise Price and the number of shares purchasable hereunder are subject to adjustment from time to time as follows: 
 12.1
[Reserved]. 
 12.2 Reclassification, etc. If the Company, at any time while this Warrant, or any portion hereof,
remains outstanding and unexpired by reclassification of securities or otherwise, shall change any of the securities as to which purchase rights under this Warrant exist into the same or a different number of securities of any other class or
classes, this Warrant shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities that were subject to the purchase rights under this
Warrant immediately prior to such reclassification or other change and the Exercise Price therefor shall be appropriately adjusted, all subject to further adjustment as provided in this Section 12. 

12.3 Split, Subdivision or Combination of Shares. If the Company at any time while this Warrant, or any portion hereof, remains
outstanding and unexpired shall split, subdivide or combine the securities as to which purchase rights under this Warrant exist, into a different number of securities of the same class, the number of Shares into which this Warrant is exercisable
shall be appropriately adjusted and the Exercise Price for such securities shall be proportionately decreased in the case of a split or subdivision or proportionately increased in the case of a combination. 

12.4 Adjustments for Dividends in Stock or Other Securities or Property. If while this Warrant, or any portion hereof, remains
outstanding and unexpired, the holders of the securities as to which purchase rights under this Warrant exist at the time shall have received, or, on or after the record date fixed for the determination of eligible stockholders, shall have become
entitled to receive, without payment therefor, other or additional stock or other securities of the Company by way of dividend, then and in each case, this Warrant shall represent the right to acquire, in addition to the number of shares of the
security receivable upon exercise of this Warrant, and without payment of any additional consideration therefor, the amount of such additional stock or other securities of the Company that such holder would hold on the date of such exercise had it
been the holder of record of the security receivable upon exercise of this Warrant on the date hereof and had thereafter, during the period from the date hereof to and including the date of such exercise, retained such shares and/or all

  
 - 6 -

 
other additional stock available by it as aforesaid during such period, giving effect to all adjustments called for during such period by the provisions of this Section 12. 

12.5 Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 12, the
Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts
upon which such adjustment or readjustment is based. The Company shall, upon the written request, at any time, of any such Holder, furnish or cause to be furnished to such Holder a like certificate setting forth: (i) such adjustments and
readjustments; (ii) the Exercise Price at the time in effect; and (iii) the number of shares that at the time would be received upon the exercise of the Warrant. 
 13. [Reserved] 
 14. [Reserved]. 

15. Representations and Warranties of the Holder. The Holder hereby represents and warrants to the Company as follows: 

15.1 Investment Intent. Holder has no intention of selling, granting any participation on or otherwise transferring this Warrant
or the Common Stock issuable upon its exercise, and Holder does not have any contract, undertaking, agreement or arrangement with any person or entity to sell, transfer or grant participation to such person or entity or to any third person or entity
with respect to this Warrant or the Common Stock issuable upon exercise of the Warrant. Such Holder understands that this Warrant and the Common Stock issuable upon exercise of this Warrant have not been and will not be registered under the
Securities Act of 1933, as amended (the “Act”), by reason of a specific exemption from the registration of the Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy
of such Holder’s representations as expressed herein or otherwise made pursuant hereto. 
 15.2 Restricted
Securities. Holder understands that this Warrant and the Common Stock issuable upon exercise of this Warrant are “restricted securities” under the Act and applicable state securities laws and that, pursuant to these laws, Holder must
hold the Warrant and the Common Stock issuable upon exercise of the Warrant indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities or an exemption from such registration and
qualification requirements is available. Holder acknowledges that neither this Warrant nor the Common Stock issuable upon exercise of this Warrant have been registered or qualified under the Act or the securities laws of any state and the Company
has no obligation to register or qualify this Warrant or the Common Stock issuable upon exercise of this Warrant for resale except as set forth in the Investors’ Rights Agreement. 

15.3 Accredited Investor Status. Holder represents to the Company that Holder is an Accredited Investor (as defined in the Act).

  
 - 7 -

 16. Descriptive Headings and Governing Law. The description headings of the several
sections and paragraphs of this Warrant are inserted for convenience only and do not constitute a part of this Warrant. This Warrant shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of
the State of California without regard to conflicts of law provisions. 
 17. Confidentiality. The Company hereby agrees
to keep the terms and conditions of this Warrant confidential and the Holder shall keep confidential any and all information and materials provided by the Company to the Holder hereunder. Notwithstanding the foregoing confidentiality obligation, a
party may disclose information relating to this Warrant as required by law, rule, regulation, court order or other legal authority, provided that (i) the disclosing party has given the other party prompt notice of such required disclosure, and
(ii) the disclosing party only discloses information that is required, in the opinion of counsel reasonably satisfactory to the other party, to be disclosed. 

  
 - 8 -

 IN WITNESS WHEREOF, the parties have executed this Warrant as of the date set forth below. 

 

							
	As of [    ]	    		  	
		
	HOLDER: [    ]	    	SOLAZYME, INC.
				
	By:	 	  
	    	By:	  	  

	    Name:	    	    Name:
	    Title:	    	    Title:

  
 - 9 -

 NOTICE OF EXERCISE 

 

	To:	Solazyme, Inc. 

(1) The undersigned hereby elects to purchase      shares of Common Stock of Solazyme, Inc.,
pursuant to the provisions of Section 3(a) of the attached Warrant, and tenders herewith payment of the purchase price for such shares in full. 
 (2) In exercising this Warrant, the undersigned hereby confirms and acknowledges that the shares of Common Stock to be issued are being acquired solely for the account of the undersigned and not as a
nominee for any other party, and for investment, and that the undersigned will not offer, sell or otherwise dispose of any such shares of Common Stock except under circumstances that will not result in a violation of the Securities Act of 1933, as
amended, or any applicable state securities laws. 
 (3) Please issue a certificate or certificates representing
said shares of Common Stock in the name of the undersigned or in such other name as is specified below: 
  

					
		  	  
	  	
		  	(Name)	  	

 (4) Please issue a new Warrant for the unexercised portion of the attached Warrant
in the name of the undersigned or in such other name as is specified below: 
  

	
	  

	Name:
	Date:

  
 - 10 -

 ASSIGNMENT FORM 
 FOR VALUE RECEIVED, the undersigned registered owner of this Warrant hereby sells, assigns and transfers unto the Assignee named below all of the rights of the undersigned under the within Warrant, with
respect to the number of shares of Common Stock set forth below: 
  

					
	Name of Assignee	 	Address	 	No. of Shares

  

and does hereby irrevocably constitute and appoint
                         Attorney to make such transfer on the books of Solazyme, Inc. maintained for the purpose, with
full power of substitution in the premises. 
 The undersigned also represents that, by assignment hereof, the Assignee acknowledges that this
Warrant and the shares of Common Stock to be issued upon exercise hereof are being acquired for investment and that the Assignee will not offer, sell or otherwise dispose of this Warrant or any shares of Common Stock to be issued hereof except under
circumstances which will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws. Further, the Assignee has acknowledged that upon exercise of this Warrant, the Assignee shall confirm in writing, in a form
satisfactory to the Company, that the shares of Common Stock so purchased are being acquired for investment and not with a view toward distribution or resale. 
  

							
	ASSIGNOR	    	ASSIGNEE
				
	Name:	 	  
	    	Name:	  	  

				
	Dated:	 	  
	    	Dated:	  	  

  
 - 11 -Second Amended and Restated 2004 Equity Incentive Plan

 Exhibit 10.2 
 SOLAZYME, INC. 
 SECOND
AMENDED AND RESTATED 
 2004 EQUITY INCENTIVE
PLAN 
 ADOPTED: FEBRUARY 8, 2008 

AMENDED ON JULY 30, 2008, DECEMBER 18, 2009,
AND SEPTEMBER 15, 2010 
 APPROVED BY
STOCKHOLDERS: FEBRUARY 8, 2008 
 TERMINATION DATE:
JANUARY 4, 2014 
  

	1.	PURPOSES. 

(a) Eligible Stock Award Recipients. The persons eligible to receive Stock Awards are Employees, Directors and
Consultants. 
 (b) Available Stock Awards. The purpose of the Plan is to provide a means by which
eligible recipients of Stock Awards may be given an opportunity to benefit from increases in value of the Common Stock through the granting of the following Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options,
(iii) Restricted Stock Awards and (iv) Stock Appreciation Rights. 
 (c) General Purpose. The
Company, by means of the Plan, seeks to retain the services of the group of persons eligible to receive Stock Awards, to secure and retain the services of new members of this group and to provide incentives for such persons to exert maximum efforts
for the success of the Company and its Affiliates. 
  

	2.	DEFINITIONS. 

 (a) “Affiliate” means any parent corporation or subsidiary corporation of the Company, whether now or hereafter existing, as those terms are defined in Sections 424(e) and
(f), respectively, of the Code. 
 (b) “Board” means the Board of Directors of
the Company. 
 (c) “Capitalization Adjustment” has the meaning ascribed to that
term in Section 11(a). 
 (d) “Change in Control” means the occurrence, in a
single transaction or in a series of related transactions, of any one or more of the following events: 
 (i)
any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities other than by virtue
of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A) on account of the acquisition of securities of the Company by any institutional investor, any affiliate
thereof or any other Exchange Act Person that acquires the 

  
 1 

 
Company’s securities in a transaction or series of related transactions that are primarily a private financing transaction for the Company or (B) solely because the level of Ownership
held by any Exchange Act Person (the “Subject Person”) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the
number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes
the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage
threshold, then a Change in Control shall be deemed to occur; 
 (ii) there is consummated a merger,
consolidation or similar transaction involving (directly or indirectly) the Company if, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own,
directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or
(B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction; 

(iii) the stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation
of the Company, or a complete dissolution or liquidation of the Company shall otherwise occur; or 
 (iv)
there is consummated a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of
the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent (50%) of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportion
as their Ownership of the Company immediately prior to such sale, lease, license or other disposition. 
 The
term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company. 

Notwithstanding the foregoing or any other provision of this Plan, the definition of Change in Control (or any analogous
term) in an individual written agreement between the Company or any Affiliate and the Participant shall supersede the foregoing definition with respect to Stock Awards subject to such agreement (it being understood, however, that if no definition of
Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply). 
 (e) “Code” means the Internal Revenue Code of 1986, as amended. 
 (f) “Committee” means a committee of one or more members of the Board appointed by the Board in accordance with Section 3(c). 

  
 2 

 (g) “Common Stock” means the common stock of
the Company. 
 (h) “Company” means Solazyme, Inc., a Delaware corporation.

 (i) “Consultant” means any person, including an advisor, (i) engaged by
the Company or an Affiliate to render consulting or advisory services and who is compensated for such services or (ii) serving as a member of the Board of Directors of an Affiliate and who is compensated for such services. However, the term
“Consultant” shall not include Directors who are not compensated by the Company for their services as Directors, and the payment of a director’s fee by the Company for services as a Director shall not cause a Director to be considered
a “Consultant” for purposes of the Plan. 
 (j) “Continuous Service”
means that the Participant’s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an
Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant’s service with the Company or an Affiliate,
shall not terminate a Participant’s Continuous Service. For example, a change in status from an employee of the Company to a consultant to an Affiliate or to a Director shall not constitute an interruption of Continuous Service. The Board or
the chief executive officer of the Company, in that party’s sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party, including sick leave, military
leave or any other personal leave. Notwithstanding the foregoing, a leave of absence shall be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company’s leave of absence policy
or in the written terms of the Participant’s leave of absence. 
 (k) “Corporate
Transaction” means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: 
 (i) a sale or other disposition of all or substantially all, as determined by the Board in its discretion, of the consolidated assets of the Company and its Subsidiaries; 

(ii) a sale or other disposition of at least ninety percent (90%) of the outstanding securities of the
Company; 
 (iii) a merger, consolidation or similar transaction following which the Company is not the
surviving corporation; or 
 (iv) a merger, consolidation or similar transaction following which the
Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into
other property, whether in the form of securities, cash or otherwise. 
 (l)
“Director” means a member of the Board. 

  
 3 

 (m) “Disability” means the inability of a
person, in the opinion of a qualified physician acceptable to the Company, to perform the major duties of that person’s position with the Company or an Affiliate because of the sickness or injury of the person. 

(n) “Employee” means any person employed by the Company or an Affiliate. Service as a
Director or payment of a director’s fee by the Company for such service or for service as a member of the Board of Directors of an Affiliate shall not be sufficient to constitute “employment” by the Company or an Affiliate.

 (o) “Entity” means a corporation, partnership or other entity. 

(p) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(q) “Exchange Act Person” means any natural person, Entity or “group” (within
the meaning of Section 13(d) or 14(d) of the Exchange Act), except that “Exchange Act Person” shall not include (A) the Company or any Subsidiary of the Company, (B) any employee benefit plan of the Company or any Subsidiary
of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (C) an underwriter temporarily holding securities pursuant to an offering of such securities, or
(D) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company. 

(r) “Fair Market Value” means, as of any date, the value of the Common Stock determined in
good faith by the Board, and in a manner consistent with Section 260.140.50 of Title 10 of the California Code of Regulations. 
 (s) “Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code and the regulations
promulgated thereunder. 
 (t) “Nonstatutory Stock Option” means an Option not
intended to qualify as an Incentive Stock Option. 
 (u) “Officer” means any
person designated by the Company as an officer. 
 (v) “Option” means an
Incentive Stock Option or a Nonstatutory Stock Option granted pursuant to the Plan. 
 (w)
“Option Agreement” means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an individual Option grant. Each Option Agreement shall be subject to the terms and conditions of
the Plan. 
 (x) “Optionholder” means a person to whom an Option is granted
pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. 
 (y)
“Own,” “Owned,” “Owner,” “Ownership” A person or Entity shall be deemed to “Own,” to have “Owned,” to be the “Owner” of, or to have acquired
“Ownership” of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, 

  
 4 

 
relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. 

(z) “Participant” means a person to whom a Stock Award is granted pursuant to the Plan or,
if applicable, such other person who holds an outstanding Stock Award. 
 (aa)
“Plan” means this Solazyme, Inc. 2004 Equity Incentive Plan. 
 (bb)
“Restricted Stock Award” means an award of shares of Common Stock, which is granted pursuant to the terms and conditions of Section 7(a). 

(cc) “Securities Act” means the Securities Act of 1933, as amended. 

(dd) “Stock Appreciation Right” means a right to receive the appreciation of Common Stock,
which is granted pursuant to the terms and conditions of Section 7(c). 
 (ee) “Stock
Award” means any right granted under the Plan, including an Option, a Restricted Stock Award and a Stock Appreciation Right. 
 (ff) “Stock Award Agreement” means a written agreement between the Company and a holder of a Stock Award evidencing the terms and conditions of an individual Stock Award
grant. Each Stock Award Agreement shall be subject to the terms and conditions of the Plan. 
 (gg)
“Subsidiary” means, with respect to the Company, (i) any corporation of which more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of
directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly,
Owned by the Company, and (ii) any partnership in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%). 

(hh) “Ten Percent Stockholder” means a person who Owns (or is deemed to Own pursuant to
Section 424(d) of the Code) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any of its Affiliates. 

 

	3.	 ADMINISTRATION. 

 (a) Administration by Board. The Board shall administer the Plan unless and until the Board delegates administration to a Committee, as provided in Section 3(c). 

(b) Powers of Board. The Board shall have the power, subject to, and within the limitations of, the express
provisions of the Plan: 
 (i) To determine from time to time which of the persons eligible under the
Plan shall be granted Stock Awards; when and how each Stock Award shall be granted; what type or combination of types of Stock Award shall be granted; the provisions of each Stock Award granted (which need not be identical), including the time or
times when a person shall be 

  
 5 

 
permitted to receive Common Stock pursuant to a Stock Award; and the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such person. 

(ii) To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke
rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the extent it shall deem necessary or expedient
to make the Plan fully effective. 
 (iii) To effect, at any time and from time to time, with the consent
of any adversely affected Optionholders, the cancellation of any outstanding Options under the Plan and the grant in substitution therefor of new Options under the Plan covering the same or a different number of shares of Common Stock. The exercise
price per share of Common Stock shall be not less than that specified under the Plan for newly granted Stock Awards except that the Board may grant an Option with a lower exercise price if such Option is granted as part of a transaction to which
Section 424(a) of the Code applies. 
 (iv) To amend the Plan or a Stock Award as provided in
Section 12. 
 (v) To terminate or suspend the Plan as provided in Section 13. 

(vi) Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to
promote the best interests of the Company and that are not in conflict with the provisions of the Plan. 

(c) Delegation to Committee. The Board may delegate administration of the Plan to a Committee or Committees of one
(1) or more members of the Board, and the term “Committee” shall apply to any person or persons to whom such authority has been delegated. If administration is delegated to a Committee, the Committee shall have, in connection with the
administration of the Plan, the powers theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board shall
thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and revest in
the Board the administration of the Plan. 
 (d) Effect of Board’s Decision. All determinations,
interpretations and constructions made by the Board in good faith shall not be subject to review by any person and shall be final, binding and conclusive on all persons. 

 

	4.	 SHARES SUBJECT TO THE PLAN. 

 (a) Share Reserve. Subject to the provisions of Section 11(a) relating to Capitalization Adjustments, the Common Stock that may be issued pursuant to Stock Awards shall not exceed in the
aggregate ten million nine hundred seventy thousand nine hundred seventy eight (10,970,978) shares of Common Stock. All of such Common Stock may be issued upon the exercise of Incentive Stock Options. 

  
 6 

 (b) Reversion of Shares to the Share Reserve. If any Stock Award
shall for any reason expire or otherwise terminate, in whole or in part, without having been exercised in full, or if any shares of Common Stock issued to a Participant pursuant to a Stock Award are forfeited back to or repurchased by the Company,
including, but not limited to, any repurchase or forfeiture caused by the failure to meet a contingency or condition required for the vesting of such shares, then the shares of Common Stock not acquired under such Stock Award shall revert to and
again become available for issuance under the Plan. If any shares subject to a Stock Award are not delivered to a Participant because such shares are withheld for the payment of taxes or the Stock Award is exercised through a reduction of shares
subject to the Stock Award (i.e., “net exercised”), then the number of shares that are not delivered shall revert to and again become available for issuance under the Plan. If the exercise price of any Stock Award is satisfied by tendering
shares of Common Stock held by the Participant (either by actual delivery or attestation), then the number of such tendered shares shall revert to and again become available for issuance under the Plan. 

(c) Source of Shares. The shares of Common Stock subject to the Plan may be unissued shares or reacquired shares,
bought on the market or otherwise. 
  

	5.	 ELIGIBILITY. 

 (a) Eligibility for Specific Stock Awards. Incentive Stock Options may be granted only to Employees. Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and
Consultants. 
 (b) Ten Percent Stockholders. A Ten Percent Stockholder shall not be granted an Incentive
Stock Option unless the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value of the Common Stock on the date of grant and the Option is not exercisable after the expiration of five (5) years
from the date of grant. 
 (c) Consultants. A Consultant shall not be eligible for the grant of a Stock
Award if, at the time of grant, either the offer or the sale of the Company’s securities to such Consultant is not exempt under Rule 701 of the Securities Act (“Rule 701”) because of the nature of the services that the Consultant is
providing to the Company, because the Consultant is not a natural person, or because of some other provision of Rule 701. 
  

	6.	 OPTION PROVISIONS. 

 Each Option shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. All Options shall be separately designated Incentive Stock Options or Nonstatutory Stock
Options at the time of grant, and, if certificates are issued, a separate certificate or certificates shall be issued for shares of Common Stock purchased on exercise of each type of Option. The provisions of separate Options need not be identical,
but each Option shall include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following provisions: 

(a) Term. Subject to the provisions of Section 5(b) regarding Ten Percent Stockholders, no Option shall be
exercisable after the expiration of ten (10) years from the date it was granted. 

  
 7 

 (b) Exercise Price of an Incentive Stock Option. Subject to the
provisions of Section 5(b) regarding Ten Percent Stockholders, the exercise price of each Incentive Stock Option shall be not less than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option on the
date the Option is granted. 
 (c) Exercise Price of a Nonstatutory Stock Option. The exercise price of
each Nonstatutory Stock Option shall be not less than one hundred (100%) of the Fair Market Value of the Common Stock subject to the Option on the date the Option is granted. 

(d) Consideration. The purchase price of Common Stock acquired pursuant to an Option shall be paid, to the extent
permitted by applicable statutes and regulations, either (i) in cash at the time the Option is exercised or (ii) at the discretion of the Board at the time of the grant of the Option (or subsequently in the case of a Nonstatutory Stock
Option) (1) by delivery to the Company of other Common Stock, (2) according to a deferred payment or other similar arrangement with the Optionholder or (3) in any other form of legal consideration that may be acceptable to the Board.
Unless otherwise specifically provided in the Option, the purchase price of Common Stock acquired pursuant to an Option that is paid by delivery to the Company of other Common Stock acquired, directly or indirectly from the Company, shall be paid
only by shares of the Common Stock of the Company that have been held for more than six (6) months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes). At any time that the Company
is incorporated in Delaware, payment of the Common Stock’s “par value,” as defined in the Delaware General Corporation Law, shall not be made by deferred payment. 

In the case of any deferred payment arrangement, interest shall be compounded at least annually and shall be charged at
the minimum rate of interest necessary to avoid (1) the treatment as interest, under any applicable provisions of the Code, of any amounts other than amounts stated to be interest under the deferred payment arrangement and (2) the
treatment of the Option as a variable award for financial accounting purposes. 
 (e) Transferability of an
Incentive Stock Option. An Incentive Stock Option shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the
foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option.

 (f) Transferability of a Nonstatutory Stock Option. A Nonstatutory Stock Option shall not be
transferable except by will, by the laws of descent and distribution or to a revocable trust and, to the extent provided in the Option Agreement, to such further extent as permitted by Section 260.140.41(c) of Title 10 of the California Code of
Regulations at the time of the grant of the Option, and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. If the Nonstatutory Stock Option does not provide for transferability, then the Nonstatutory Stock Option
shall not be transferable except by will, by the laws of descent and distribution or to a revocable trust and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding the foregoing, the Optionholder may,
by delivering written notice to the Company, in a form satisfactory to the Company, designate a 

  
 8 

 
third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option. 

(g) Vesting Generally. The total number of shares of Common Stock subject to an Option may, but need not, vest and
therefore become exercisable in periodic installments that may, but need not, be equal. The Option may be subject to such other terms and conditions on the time or times when it may be exercised (which may be based on performance or other criteria)
as the Board may deem appropriate. The vesting provisions of individual Options may vary. The provisions of this Section 6(g) are subject to any Option provisions governing the minimum number of shares of Common Stock as to which an Option may
be exercised. 
 (h) [Intentionally Omitted.]. 

(i) Termination of Continuous Service. In the event that an Optionholder’s Continuous Service terminates
(other than upon the Optionholder’s death or Disability), the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination) but only within such period of
time ending on the earlier of (i) the date three (3) months following the termination of the Optionholder’s Continuous Service (or such longer or shorter period specified in the Option Agreement, which period shall not be less than
thirty (30) days unless such termination is for cause), or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time
specified in the Option Agreement, the Option shall terminate. 
 (j) Extension of Termination Date. An
Optionholder’s Option Agreement may also provide that if the exercise of the Option following the termination of the Optionholder’s Continuous Service (other than upon the Optionholder’s death or Disability) would be prohibited at any
time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration of the term of the Option set forth in
Section 6(a) or (ii) the expiration of a period of three (3) months after the termination of the Optionholder’s Continuous Service during which the exercise of the Option would not be in violation of such registration
requirements. 
 (k) Disability of Optionholder. In the event that an Optionholder’s Continuous
Service terminates as a result of the Optionholder’s Disability, the Optionholder may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination), but only within such
period of time ending on the earlier of (i) the date twelve (12) months following such termination (or such longer or shorter period specified in the Option Agreement, which period shall not be less than six (6) months) or
(ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time specified herein, the Option shall terminate. 

(l) Death of Optionholder. In the event that (i) an Optionholder’s Continuous Service terminates as a
result of the Optionholder’s death or (ii) the Optionholder dies within the period (if any) specified in the Option Agreement after the termination of the Optionholder’s Continuous Service for a reason other than death, then the
Option may be exercised (to the extent 

  
 9 

 
the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder’s estate, by a person who acquired the right to exercise the Option by bequest or
inheritance or by a person designated to exercise the option upon the Optionholder’s death pursuant to Section 6(e) or 6(f), but only within the period ending on the earlier of (1) the date eighteen (18) months following the date
of death (or such longer or shorter period specified in the Option Agreement, which period shall not be less than six (6) months) or (2) the expiration of the term of such Option as set forth in the Option Agreement. If, after death, the
Option is not exercised within the time specified herein, the Option shall terminate. 
 (m) Early
Exercise. The Option may, but need not, include a provision whereby the Optionholder may elect at any time before the Optionholder’s Continuous Service terminates to exercise the Option as to any part or all of the shares of Common Stock
subject to the Option prior to the full vesting of the Option. Subject to the “Repurchase Limitation” in Section 10(h), any unvested shares of Common Stock so purchased may be subject to a repurchase option in favor of the Company or
to any other restriction the Board determines to be appropriate. Provided that the “Repurchase Limitation” in Section 10(h) is not violated, the Company will not exercise its repurchase option until at least six (6) months (or
such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes) have elapsed following exercise of the Option unless the Board otherwise specifically provides in the Option. 

(n) Right of Repurchase. Subject to the “Repurchase Limitation” in Section 10(h), the Option may,
but need not, include a provision whereby the Company may elect to repurchase all or any part of the vested shares of Common Stock acquired by the Optionholder pursuant to the exercise of the Option. Provided that the “Repurchase
Limitation” in Section 10(h) is not violated, the Company will not exercise its repurchase option until at least six (6) months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting
purposes) have elapsed following exercise of the Option unless otherwise specifically provided in the Option. 

(o) Right of First Refusal. The Option may, but need not, include a provision whereby the Company may elect to
exercise a right of first refusal following receipt of notice from the Optionholder of the intent to transfer all or any part of the shares of Common Stock received upon the exercise of the Option. Except as expressly provided in this
Section 6(o) or in the Stock Award Agreement for the Option, such right of first refusal shall otherwise comply with any applicable provisions of the Bylaws of the Company. The Company will not exercise its right of first refusal until at least
six (6) months (or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes) have elapsed following exercise of the Option unless otherwise specifically provided in the Option. 

 

	7.	 PROVISIONS OF STOCK AWARDS OTHER THAN OPTIONS. 

(a) Restricted Stock Awards. Each Restricted Stock Award shall be in such form and shall contain such terms and
conditions as the Board shall deem appropriate. The terms and conditions of the Restricted Stock Award agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award agreements need not be identical;
provided however that each Restricted Stock Award agreement shall include (through 

  
 10 

 
incorporation of provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: 

(i) Purchase Price. At the time of grant of a Restricted Stock Award, the Board will determine the price to be
paid by the Participant for each share subject to the Restricted Stock Award. A Restricted Stock Award may be awarded as a stock bonus (i.e., with no cash purchase price to be paid) to the extent permissible under applicable law. 

(ii) Consideration. At the time of the grant of a Restricted Stock Award, the Board will determine the
consideration permissible for the payment of the purchase price of the Restricted Stock Award. The purchase price of Common Stock acquired pursuant to the Restricted Stock Award shall be paid in one of the following ways: (i) in cash at the
time of purchase; (ii) at the discretion of the Board, according to a deferred payment or other similar arrangement with the Participant; (iii) by services rendered or to be rendered to the Company; (iv) in any other form of legal
consideration that may be acceptable to the Board; provided, however, that at any time that the Company is incorporated in Delaware, then payment of the Common Stock’s “par value,” as defined in the Delaware General Corporation
Law, shall not be made by deferred payment and must be paid in a form of consideration that is permissible under the Delaware General Corporation Law. 
 (iii) Vesting. Subject to the “Repurchase Limitation” in Section 10(h), shares of Common Stock acquired under a Restricted Stock Award may, but need not, be subject to a share
repurchase option in favor of the Company in accordance with a vesting schedule to be determined by the Board. 

(iv) Termination of Participant’s Continuous Service. Subject to the “Repurchase Limitation” in
Section 10(h), in the event that a Participant’s Continuous Service terminates, the Company may repurchase or otherwise reacquire any or all of the shares of Common Stock held by the Participant that have not vested as of the date of
termination under the terms of the Restricted Stock Award agreement. Provided that the “Repurchase Limitation” in Section 10(h) is not violated, the Company will not exercise its repurchase option until at least six (6) months
(or such longer or shorter period of time required to avoid a charge to earnings for financial accounting purposes) have elapsed following the purchase of the restricted stock unless otherwise determined by the Board or provided in the Restricted
Stock Award agreement. 
 (v) Transferability. Rights to acquire shares of Common Stock under the
Restricted Stock Award agreement shall not be transferable except by will, by the laws of descent and distribution or to a revocable trust and, to the extent provided in the Restricted Stock Award agreement, to such further extent as permitted by
Section 260.140.42(b) of Title 10 of the California Code of Regulations and shall be exercisable during the lifetime of the Participant only by the Participant. 

(b) Stock Appreciation Rights. Each Stock Appreciation Right agreement shall be in such form and shall contain
such terms and conditions as the Board shall deem appropriate. The terms and conditions of Stock Appreciation Right agreements may change from time to time, and the terms and conditions of separate Stock Appreciation Right agreements need not be
identical, but each Stock Appreciation Right agreement shall include (through incorporation of 

  
 11 

 
the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: 

(i) Calculation of Appreciation. Each Stock Appreciation Right will be denominated in shares of Common Stock
equivalents. The appreciation distribution payable on the exercise of a Stock Appreciation Right will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of the Stock
Appreciation Right) of Common Stock over (B) an amount that will be determined by the Committee at the time of grant of the Stock Appreciation Right, such amount not to be lower than the Fair Market Value of the Common Stock on the date the
Stock Appreciation Right is granted, multiplied by the number of shares of Common Stock equivalents in which the Participant is vested under such Stock Appreciation Right and with respect to which the Participant is exercising the Stock Appreciation
Right on such date. 
 (ii) Vesting. At the time of the grant of a Stock Appreciation Right, the Board
may impose such restrictions or conditions to the vesting of such Right as it deems appropriate; provided, however, that a Stock Appreciation Right that could be settled in shares of Common Stock shall be subject to the provision of
Section 10(h). 
 (iii) Exercise. To exercise any outstanding Stock Appreciation Right, the
Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Rights agreement evidencing such Right. 

(iv) Payment. The appreciation distribution in respect of a Stock Appreciation Right may be paid in Common Stock,
in cash, or any combination of the two, as the Board deems appropriate. 
 (c) Termination of Continuous Service. If a
Participant’s Continuous Service terminates for any reason, any unvested Stock Appreciation Rights shall be forfeited and any vested Stock Appreciation Rights shall be automatically redeemed. 

 

	8.	 COVENANTS OF THE COMPANY. 

 (a) Availability of Shares. During the terms of the Stock Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Stock Awards.

 (b) Securities Law Compliance. The Company shall seek to obtain from each regulatory commission or
agency having jurisdiction over the Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; provided, however, that this undertaking shall not require the
Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission or
agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such
Stock Awards unless and until such authority is obtained. 

  
 12 

	9.	 USE OF PROCEEDS FROM STOCK. 

 Proceeds from the sale of Common Stock pursuant to Stock Awards shall constitute general funds of the Company. 
  

	10.	 MISCELLANEOUS. 

 (a) Acceleration of Exercisability and Vesting. The Board shall have the power to accelerate the time at which a Stock Award may first be exercised or the time during which a Stock Award or any
part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Stock Award stating the time at which it may first be exercised or the time during which it will vest. 

(b) Stockholder Rights. No Participant shall be deemed to be the holder of, or to have any of the rights of a
holder with respect to, any shares of Common Stock subject to such Stock Award unless and until such Participant has satisfied all requirements for exercise of the Stock Award pursuant to its terms. 

(c) No Employment or other Service Rights. Nothing in the Plan or any instrument executed or Stock Award granted
pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or shall affect the right of the Company or an Affiliate to terminate
(i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant’s agreement with the Company or an Affiliate or (iii) the service of a
Director pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. 

(d) Incentive Stock Option $100,000 Limitation. To the extent that the aggregate Fair Market Value (determined at
the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and its Affiliates) exceeds one hundred thousand dollars
($100,000), the Options or portions thereof that exceed such limit (according to the order in which they were granted) shall be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of a Stock Award Agreement. 

(e) Investment Assurances. The Company may require a Participant, as a condition of exercising or acquiring Common
Stock under any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant’s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory
to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Stock Award; and
(ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant’s own account and not with any present intention of selling or otherwise
distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, shall be inoperative if (1) the issuance of the shares of Common Stock 

  
 13 

 
upon the exercise or acquisition of Common Stock under the Stock Award has been registered under a then currently effective registration statement under the Securities Act or (2) as to any
particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on
stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. 

(f) Withholding Obligations. To the extent provided by the terms of a Stock Award Agreement, the Participant may satisfy any
federal, state or local tax withholding obligation relating to the exercise or acquisition of Common Stock under a Stock Award by any of the following means (in addition to the Company’s right to withhold from any compensation paid to the
Participant by the Company) or by a combination of such means: (i) tendering a cash payment; (ii) authorizing the Company to withhold shares of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result
of the exercise or acquisition of Common Stock under the Stock Award; provided, however, that no shares of Common Stock are withheld with a value exceeding the minimum amount of tax required to be withheld by law (or such lower amount as may
be necessary to avoid variable award accounting); or (iii) delivering to the Company owned and unencumbered shares of Common Stock. 
 (g) [Intentionally Omitted.] 
 (h) Repurchase Limitation. The terms
of any repurchase option shall be specified in the Stock Award, and the repurchase price may be either the Fair Market Value of the shares of Common Stock on the date of termination of Continuous Service or the lower of (i) the Fair Market
Value of the shares of Common Stock on the date of repurchase or (ii) their original purchase price: The right to repurchase shall be exercised for cash or cancellation of purchase money indebtedness for the shares of Common Stock within one
(1) year of the termination of Continuous Service (or in the case of shares of Common Stock issued upon exercise of Options after such date of termination, within one (1) year after the date of the exercise) or such longer period as may be
agreed to by the Company and the Participant (for example, for purposes of satisfying the requirements of Section 1202(c)(3) of the Code regarding “qualified small business stock”) 

 

	11.	ADJUSTMENTS UPON CHANGES IN STOCK. 

 (a) Capitalization Adjustments. If any change is made in, or other event occurs with respect to, the Common Stock subject to the Plan or subject to any Stock Award without the receipt of
consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating distribution, combination of shares, exchange of shares,
change in corporate structure or other transaction not involving the receipt of consideration by the Company (each a “Capitalization Adjustment”), the Plan will be appropriately adjusted in the class(es) and maximum number of securities
subject to the Plan pursuant to Sections 4(a) and 4(b) and the outstanding Stock Awards will be appropriately adjusted in the class(es) and number of securities and price per share of Common Stock subject to such outstanding Stock Awards. The

  
 14 

 
Board shall make such adjustments, and its determination shall be final, binding and conclusive. (The conversion of any convertible securities of the Company shall not be treated as a transaction
“without receipt of consideration” by the Company.) 
 (b) Dissolution or Liquidation. In the
event of a dissolution or liquidation of the Company, then all outstanding Options shall terminate immediately prior to the completion of such dissolution or liquidation, and shares of Common Stock subject to the Company’s repurchase option may
be repurchased by the Company notwithstanding the fact that the holder of such stock is still in Continuous Service. 
 (c) Corporate Transaction. In the event of a Corporate Transaction, any surviving corporation or acquiring corporation may assume or continue any or all Stock Awards outstanding under the Plan or
may substitute similar stock awards for Stock Awards outstanding under the Plan (it being understood that similar stock awards include, but are not limited to, awards to acquire the same consideration paid to the stockholders or the Company, as the
case may be, pursuant to the Corporate Transaction), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to Stock Awards may be assigned by the Company to the successor of the Company (or such
successor’s parent company), if any, in connection with such Corporate Transaction. In the case of Options, such assumption or substitution shall be effectuated in a manner that complies with Section 424(a) of the Code (whether or not such
Options are Incentive Stock Options or Nonstatutory Stock Options). In the event that any surviving corporation or acquiring corporation does not assume or continue any or all such outstanding Stock Awards or substitute similar stock awards for such
outstanding Stock Awards, then with respect to Stock Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Corporate Transaction,
the vesting of such Stock Awards (and, if applicable, the time at which such Stock Awards may be exercised) shall (contingent upon the effectiveness of the Corporate Transaction) be accelerated in full to a date prior to the effective time of such
Corporate Transaction as the Board shall determine (or, if the Board shall not determine such a date, to the date that is five (5) days prior to the effective time of the Corporate Transaction), the Stock Awards shall terminate if not exercised
(if applicable) at or prior to such effective time, and any reacquisition or repurchase rights held by the Company with respect to such Stock Awards held by Participants whose Continuous Service has not terminated shall (contingent upon the
effectiveness of the Corporate Transaction) lapse. With respect to any other Stock Awards outstanding under the Plan that have not been assumed, continued or substituted, the vesting of such Stock Awards (and, if applicable, the time at which such
Stock Award may be exercised) shall not be accelerated, unless otherwise provided in a written agreement between the Company or any Affiliate and the holder of such Stock Award, and such Stock Awards shall terminate if not exercised (if applicable)
prior to the effective time of the Corporate Transaction. 
 (d) Change in Control. A Stock Award held by
any Participant whose Continuous Service has not terminated prior to the effective time of a Change in Control may be subject to additional acceleration of vesting and exercisability upon or after such event as may be provided in the Stock Award
Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration shall occur. 

  
 15 

	12.	 AMENDMENT OF THE PLAN AND STOCK AWARDS. 

(a) Amendment of Plan. The Board at any time, and from time to time, may amend the Plan. However, except as
provided in Section 11(a) relating to Capitalization Adjustments, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary to satisfy the requirements of Section 422
of the Code. 
 (b) Stockholder Approval. The Board, in its sole discretion, may submit any other
amendment to the Plan for stockholder approval. 
 (c) Contemplated Amendments. It is expressly
contemplated that the Board may amend the Plan in any respect the Board deems necessary or advisable to provide eligible Employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated
thereunder relating to Incentive Stock Options and/or to bring the Plan and/or Incentive Stock Options granted under it into compliance therewith. 
 (d) No Impairment of Rights. Rights under any Stock Award granted before amendment of the Plan shall not be impaired by any amendment of the Plan unless (i) the Company requests the consent of
the Participant and (ii) the Participant consents in writing. 
 (e) Amendment of Stock Awards. The
Board at any time, and from time to time, may amend the terms of any one or more Stock Awards; provided, however, that the rights under any Stock Award shall not be impaired by any such amendment unless (i) the Company requests the
consent of the Participant and (ii) the Participant consents in writing. 
  

	13.	 TERMINATION OR SUSPENSION OF THE PLAN. 

(a) Plan Term. The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall
terminate on the day before the tenth (10th) anniversary of the date the Plan is adopted by the Board or approved by the stockholders of the Company, whichever is earlier. No Stock Awards may be granted under the Plan while the Plan is
suspended or after it is terminated. 
 (b) No Impairment of Rights. Suspension or termination of the
Plan shall not impair rights and obligations under any Stock Award granted while the Plan is in effect except with the written consent of the Participant. 
  

	14.	 EFFECTIVE DATE OF PLAN. 

 The Plan shall become effective as determined by the Board, provided, however, that if Stockholder approval of the Plan is not obtained within twelve (12) months before or after the date the
Plan is adopted by the Board, then any Stock Award exercised before the Stockholder approval is obtained must be rescinded. 
  

	15.	 CHOICE OF LAW. 

 The law of the State of California shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to such state’s conflict of laws rules. 

  
 16 

 SOLAZYME, INC. 
 SECOND AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN 
 NOTICE OF STOCK
OPTION GRANT 
 SOLAZYME, INC. (the “Company”), pursuant to its
SECOND AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN (the “Plan”), hereby grants to Option Holder listed below
(“Option Holder”) an option to purchase the number of shares of the Company’s COMMON stock set forth below (the “Option”), subject to the terms and conditions of this Notice of Stock Option Grant, the Plan, the Stock
Option Agreement, the Notice of Exercise, and any ancillary documents, all of which are attached hereto and incorporated herein in their entirety. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in
this Notice of Stock Option Grant, the Stock Option Agreement, the Notice of Exercise, and any ancillary documents. 
  

			
	 Name of Option Holder:

 
	 	 
	 Grant
Date:
  
	 	 
	 Vesting Commencement Date:

 
	 	 
	 Total Number
of Shares Granted:
  
	 	 
	 Exercise Price per Share:

 
	 	 
	 Total Exercise
Price:
  
	 	 
	 Expiration Date:

 
	 	 

  

					
	Type of Option Grant:	  	 ̈ Incentive Stock Option (ISO)1	 	 ̈ Nonstatutory Stock Option (NSO)
		
	Vesting Schedule:	  	 Subject to Option Holder providing Continuous Service (as defined in the Plan) through such dates, or as otherwise set forth in the Plan, this
Option is subject to a four (4) year vesting schedule in which 25% of the number of shares subject to this Option shall vest on the first anniversary of the Vesting Commencement Date, with the remainder of shares subject to this Option vesting
monthly over 36 consecutive months thereafter.

			
	Exercise Schedule:	  	 ̈ Early Exercise Permitted	 	 ̈ Same as Vesting Schedule
		
	Payment:	  	 By one or a combination of the following items (described in the Stock Option Agreement): cash or check; pursuant to a Regulation T Program if the
Shares are publicly traded and the Company then has a Regulation T Program; or delivery of already-owned shares if the Shares are publicly traded.

 Additional Terms / Acknowledgments: The undersigned Option Holder hereby acknowledges receipt of this Notice of Stock Option Grant, the Plan, the Stock Option Agreement (and exhibits thereto), the
Notice of Exercise, and any ancillary documents, and accepts this Option subject to all of the terms and provisions thereof. Option Holder further represents that he or she has reviewed this Notice of Stock Option Grant, the Plan, the Stock Option
Agreement, the Notice of Exercise, and any ancillary documents, has had an opportunity to obtain the advice of counsel (legal and tax) prior to accepting the Option, fully understands and agrees to be bound by the terms and conditions thereof, and
makes each of the representations required to be made by Option Holder thereunder. Option Holder acknowledges that the Company has given no legal or tax advice concerning the Option. Option Holder acknowledges and agrees that the vesting of the
shares pursuant to the Option is earned only by continuing employment or consultancy at the will of the Company (not through the act of being hired, being granted this Option or acquiring shares hereunder). Option Holder further acknowledges and
agrees that nothing in this Notice of Stock Option Grant, the Plan, the Stock Option Agreement, the Notice of Exercise, or any ancillary documents shall confer upon Option Holder any right with respect to continuation of employment or consultancy by
the Company, nor shall it interfere in any way with Option Holder’s right or the Company’s right to terminate Option Holder’s employment or consultancy at any time, with or without cause and with or without prior notice. Option Holder
further acknowledges that as of the Grant Date this Notice of Stock Option Grant, the Plan, and the Stock Option Agreement set forth the entire understanding between Option Holder and the Company regarding acquisition of stock in the Company and
supersede all prior oral and written agreements on that subject with the exception of options previously granted and delivered to Option Holder under the Plan that have not terminated. 

 
  
 1 If this is
an incentive stock option, it (plus Option Holder’s other outstanding incentive stock options) cannot be first exercisable for more than $100,000 in any calendar year. Any excess over $100,000 is a nonstatutory stock option. 

									
	SOLAZYME, INC.	  	OPTION HOLDER
				
	By:	 	  
	  		  	  

									
		 	(Authorized Signature)	  		  	(Signature)
				
	Name:	 	  
	  		  	
				
	Title:	 	  
	  		  	
					
	Date:	 	  
	  		  	Date:	 	  

 ATTACHMENTS: 
 1. Second Amended and Restated 2004 Equity Incentive Plan 

2. Amended and Restated 2004 Equity Incentive Plan Stock Option Agreement 
 3. Notice of Exercise 
 4. Early Exercise Stock Purchase Agreement under the Amended and Restated
2004 Equity Incentive Plan, including: 
  

	 	•	 	 Exhibit A – Notice of Exercise 

  

	 	•	 	 Exhibit B – Assignment Separate from Certificate 

 

	 	•	 	 Exhibit C – 83(b) Election Form 

 SOLAZYME, INC. 

SECOND AMENDED AND RESTATED 2004 EQUITY
INCENTIVE PLAN 
 STOCK OPTION AGREEMENT

 (INCENTIVE STOCK OPTION OR NONSTATUTORY
STOCK OPTION) 
 Pursuant to your Stock Option Grant Notice (“Grant
Notice”) and this Stock Option Agreement, SOLAZYME, INC. (the “Company”) has granted you an option under its SECOND AMENDED AND
RESTATED 2004 EQUITY INCENTIVE PLAN (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the
exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan. 

The details of your option are as follows: 

1. VESTING. Subject to the limitations contained herein, your option will vest as provided in your
Grant Notice, provided that vesting will cease upon the termination of your Continuous Service. 
 2.
NUMBER OF SHARES AND EXERCISE PRICE. The number of shares of Common Stock subject to your option and your exercise price per share referenced in your Grant
Notice may be adjusted from time to time for Capitalization Adjustments. 
 3. EXERCISE
PRIOR TO VESTING (“EARLY EXERCISE”). If permitted in your Grant Notice (i.e., the “Exercise Schedule” indicates that “Early Exercise” of
your option is permitted) and subject to the provisions of your option, you may elect at any time that is both (i) during the period of your Continuous Service and (ii) during the term of your option, to exercise all or part of your
option, including the nonvested portion of your option; provided, however, that: 
 (a) a partial
exercise of your option shall be deemed to cover first vested shares of Common Stock and then the earliest vesting installment of unvested shares of Common Stock; 

(b) any shares of Common Stock so purchased from installments that have not vested as of the date of exercise
shall be subject to the purchase option in favor of the Company as described in the Company’s form of Early Exercise Stock Purchase Agreement; 
 (c) you shall enter into the Company’s form of Early Exercise Stock Purchase Agreement with a vesting schedule that will result in the same vesting as if no early exercise had occurred; and

 (d) if your option is an Incentive Stock Option, then, to the extent that the aggregate Fair Market
Value (determined at the time of grant) of the shares of Common Stock with respect to which your option plus all other Incentive Stock Options you hold are exercisable for the first time by you during any calendar year (under all plans of the
Company and its Affiliates) exceeds one hundred thousand dollars ($100,000), your option(s) or portions thereof 

  

					
		  	1.	  	

 
that exceed such limit (according to the order in which they were granted) shall be treated as Nonstatutory Stock Options. 

4. METHOD OF PAYMENT. Payment of the exercise price is due in full
upon exercise of all or any part of your option. You may elect to make payment of the exercise price in cash or by check or in any other manner permitted by your Grant Notice, which may include one or more of the following: 

(a) In the Company’s sole discretion at the time your option is exercised and provided that at the time of
exercise the Common Stock is publicly traded and quoted regularly in The Wall Street Journal, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Stock, results
in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds. 

(b) Provided that at the time of exercise the Common Stock is publicly traded and quoted regularly in The Wall
Street Journal, by delivery of already-owned shares of Common Stock either that you have held for the period required to avoid a charge to the Company’s reported earnings (generally six (6) months) or that you did not acquire, directly
or indirectly from the Company, that are owned free and clear of any liens, claims, encumbrances or security interests, and that are valued at Fair Market Value on the date of exercise. “Delivery” for these purposes, in the sole discretion
of the Company at the time you exercise your option, shall include delivery to the Company of your attestation of ownership of such shares of Common Stock in a form approved by the Company. Notwithstanding the foregoing, you may not exercise your
option by tender to the Company of Common Stock to the extent such tender would violate the provisions of any law, regulation or agreement restricting the redemption of the Company’s stock. 

(c) Pursuant to the following deferred payment alternative: 

(i) Not less than one hundred percent (100%) of the aggregate exercise price, plus accrued interest, shall
be due four (4) years from date of exercise or, at the Company’s election, upon termination of your Continuous Service. 
 (ii) Interest shall be compounded at least annually and shall be charged at the minimum rate of interest necessary to avoid (1) the treatment as interest, under any applicable provisions of
the Code, of any amounts other than amounts stated to be interest under the deferred payment arrangement and (2) the treatment of the Option as a variable award for financial accounting purposes. 

(iii) At any time that the Company is incorporated in Delaware, payment of the Common Stock’s “par
value,” as defined in the Delaware General Corporation Law, shall be made in cash and not by deferred payment. 
 (iv) In order to elect the deferred payment alternative, you must, as a part of your written notice of exercise, give notice of the election of this payment alternative and, in order to secure the
payment of the deferred exercise price to the Company hereunder, if the Company so requests, you must tender to the Company, in its sole discretion, a full recourse 

  

					
		  	2.	  	

 
promissory note or a promissory note and a pledge agreement covering the purchased shares of Common Stock, both in form and substance satisfactory to the Company, or such other or additional
documentation as the Company may request. 
 5. WHOLE SHARES. You may
exercise your option only for whole shares of Common Stock. 
 6. SECURITIES
LAW COMPLIANCE. Notwithstanding anything to the contrary contained herein, you may not exercise your option unless the shares of Common Stock issuable upon such exercise are then registered under the Securities Act
or, if such shares of Common Stock are not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act. The exercise of your option also must comply with
other applicable laws and regulations governing your option, and you may not exercise your option if the Company determines that such exercise would not be in material compliance with such laws and regulations. 

7. TERM. You may not exercise your option before the commencement or after the expiration of its
term. The term of your option commences on the Date of Grant and expires upon the earliest of the following: 

(a) three (3) months after the termination of your Continuous Service for any reason other than your
Disability or death, provided that if during any part of such three (3) month period your option is not exercisable solely because of the condition set forth in Section 6, your option shall not expire until the earlier of the Expiration
Date or until it shall have been exercisable for an aggregate period of three (3) months after the termination of your Continuous Service; 
 (b) twelve (12) months after the termination of your Continuous Service due to your Disability; 
 (c) eighteen (18) months after your death if you die either during your Continuous Service or within three (3) months after your Continuous Service terminates; 

(d) the Expiration Date indicated in your Grant Notice; or 

(e) the day before the tenth (10th) anniversary of the Date of Grant. 

If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an
Incentive Stock Option, the Code requires that at all times beginning on the date of grant of your option and ending on the day three (3) months before the date of your option’s exercise, you must be an employee of the Company or an
Affiliate, except in the event of your death or your permanent and total disability, as defined in Section 22(e) of the Code. (The definition of disability in Section 22(e) of the Code is different from the definition of the Disability
under the Plan). The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to
provide services to the Company or an Affiliate as a Consultant or Director after your 

  

					
		  	3.	  	

 
employment terminates or if you otherwise exercise your option more than three (3) months after the date your employment with the Company or an Affiliate terminates. 

8. EXERCISE. 

(a) You may exercise the vested portion of your option (and the unvested portion of your option if your Grant
Notice so permits) during its term by delivering a Notice of Exercise (in a form designated by the Company) together with the exercise price to the Secretary of the Company, or to such other person as the Company may designate, during regular
business hours, together with such additional documents as the Company may then require. 
 (b) By
exercising your option you agree that, as a condition to any exercise of your option, the Company may require you to enter into an arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising
by reason of (1) the exercise of your option, (2) the lapse of any substantial risk of forfeiture to which the shares of Common Stock are subject at the time of exercise, or (3) the disposition of shares of Common Stock acquired upon
such exercise. 
 (c) If your option is an Incentive Stock Option, by exercising your option you agree
that you will notify the Company in writing within fifteen (15) days after the date of any disposition of any of the shares of the Common Stock issued upon exercise of your option that occurs within two (2) years after the date of your
option grant or within one (1) year after such shares of Common Stock are transferred upon exercise of your option. 
 (d) By exercising your option you agree that you shall not sell, dispose of, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction
with the same economic effect as a sale, any shares of Common Stock or other securities of the Company held by you, for a period of time specified by the managing underwriter(s) (not to exceed one hundred eighty (180) days) following the
effective date of a registration statement of the Company filed under the Securities Act (the “Lock Up Period”); provided, however, that nothing contained in this section shall prevent the exercise of a repurchase option, if any, in
favor of the Company during the Lock Up Period. You further agree to execute and deliver such other agreements as may be reasonably requested by the Company and/or the underwriter(s) that are consistent with the foregoing or that are necessary to
give further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to your shares of Common Stock until the end of such period. The underwriters of the Company’s stock are
intended third party beneficiaries of this Section 8(d) and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 

9. TRANSFERABILITY. 

(a) If your option is an Incentive Stock Option, your option is not transferable, except by will or by the laws of
descent and distribution, and is exercisable during your life only by you. Notwithstanding the foregoing, by delivering written notice to the Company, in a form satisfactory to the Company, you may designate a third party who, in the event of your
death, shall thereafter be entitled to exercise your option. 

  

					
		  	4.	  	

 (b) If your option is a Nonstatutory Stock Option, you option is not
transferable, except (i) by will or by the laws of descent and distribution, (ii) to a revocable trust and (iii) with the prior written approval of the Company, as permitted under Rule 701 of the Securities Act. 

10. RIGHT OF FIRST REFUSAL. Shares of Common Stock
that you acquire upon exercise of your option are subject to any right of first refusal that may be described in the Company’s bylaws in effect at such time the Company elects to exercise its right; provided, however, that if your option
is an Incentive Stock Option and the right of first refusal described in the Company’s bylaws in effect at the time the Company elects to exercise its right is more beneficial to you than the right of first refusal described in the
Company’s bylaws on the Date of Grant, then the right of first refusal described in the Company’s bylaws on the Date of Grant shall apply. The Company’s right of first refusal shall expire on the Listing Date. For purposes of this
Agreement, Listing Date shall mean the first date upon which any security of the Company is listed (or approved for listing) upon notice of issuance on a national securities exchange or on the National Market System of the Nasdaq Stock Market (or
any successor to that entity). 
 11. RIGHT OF REPURCHASE.
To the extent provided in the Company’s bylaws in effect at such time the Company elects to exercise its right, the Company shall have the right to repurchase all or any part of the shares of Common Stock you acquire pursuant to the exercise of
your option. 
 12. OPTION NOT A SERVICE
CONTRACT. Your option is not an employment or service contract, and nothing in your option shall be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company or an Affiliate, or of
the Company or an Affiliate to continue your employment. In addition, nothing in your option shall obligate the Company or an Affiliate, their respective stockholders, Boards of Directors, Officers or Employees to continue any relationship that you
might have as a Director or Consultant for the Company or an Affiliate. 
 13. WITHHOLDING
OBLIGATIONS. 
 (a) At the time you exercise your option, in whole or in part, or at
any time thereafter as requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a “cashless exercise” pursuant
to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an
Affiliate, if any, which arise in connection with the exercise of your option. 
 (b) Upon your request
and subject to approval by the Company, in its sole discretion, and compliance with any applicable legal conditions or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of
your option a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date of exercise, not in excess of the minimum amount of tax required to be withheld by law (or such lower amount as may be
necessary to avoid variable 

  

					
		  	5.	  	

 
award accounting). If the date of determination of any tax withholding obligation is deferred to a date later than the date of exercise of your option, share withholding pursuant to the preceding
sentence shall not be permitted unless you make a proper and timely election under Section 83(b) of the Code, covering the aggregate number of shares of Common Stock acquired upon such exercise with respect to which such determination is
otherwise deferred, to accelerate the determination of such tax withholding obligation to the date of exercise of your option. Notwithstanding the filing of such election, shares of Common Stock shall be withheld solely from fully vested shares of
Common Stock determined as of the date of exercise of your option that are otherwise issuable to you upon such exercise. Any adverse consequences to you arising in connection with such share withholding procedure shall be your sole responsibility.

 (c) You may not exercise your option unless the tax withholding obligations of the Company and/or any
Affiliate are satisfied. Accordingly, you may not be able to exercise your option when desired even though your option is vested, and the Company shall have no obligation to issue a certificate for such shares of Common Stock or release such shares
of Common Stock from any escrow provided for herein unless such obligations are satisfied. 
 14.
NOTICES. Any notices provided for in your option or the Plan shall be given in writing and shall be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after
deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company. 
 15. GOVERNING PLAN DOCUMENT. Your option is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your option,
and is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of your option and those of the Plan,
the provisions of the Plan shall control. 

  

					
		  	6.	  	

 SOLAZYME, INC. 
 SECOND AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN 
 RESTRICTED STOCK
AGREEMENT 
 THIS AGREEMENT, dated as of
                                 (the “Effective Date”), is by and
between Solazyme, Inc., a Delaware corporation (the “Company”), and
                                 (the “Participant”). 

WITNESSETH: 
 WHEREAS, Participant is currently providing consulting services to the Company; and 
 WHEREAS, the Company wishes to grant Participant      shares of the Company’s common stock, subject to the terms and conditions of the Company’s Second Amended
and Restated 2004 Equity Incentive Plan (the “Plan”) and this Restricted Stock Agreement (the “Agreement”) as consideration for providing certain consulting services to the Company. 

NOW, THEREFORE, IT IS AGREED between the parties as follows: 

 

	 	1.	INCORPORATION OF PLAN BY REFERENCE 

 This Agreement is subject to all of the terms and conditions set forth in the Plan. If there is a conflict between the terms of this Agreement and the terms of the Plan, the terms of the Plan shall
control. All defined terms used herein and not otherwise defined herein shall have the respective meanings defined in the Plan. 
  

	 	2.	TERMS OF GRANT 

 As of the
Effective Date, the Company grants to Participant                              shares (the
“Shares”) of common stock with a fair market value of      per share. As used in this Agreement, “Shares” refers to the Shares granted to Participant, pursuant to this Agreement and includes all
securities received (a) in replacement of the Shares, (b) as a result of stock dividends or stock splits in respect of the Shares, and (c) in replacement of the Shares in a merger, recapitalization, reorganization or similar corporate
transaction. 
  

	 	3.	LIMITATIONS ON TRANSFER 

(a) Restrictions on Transfer. Participant shall not sell, assign, hypothecate, donate, encumber or otherwise dispose of any
interest in such Shares except in compliance with the provisions herein and applicable securities laws. Furthermore, the Shares are subject to a right of first refusal in the Company’s Bylaws in favor of the Company or its assignees.

 (b) Dispositions of Shares. Participant hereby agrees that Participant shall make no disposition of the Shares unless
and until: 

  
 1 

 (i) Participant shall have notified the Company of the proposed disposition and provided a
written summary of the terms and conditions of the proposed disposition; 
 (ii) Participant shall have complied with all
requirements of this Agreement applicable to the disposition of the Shares; 
 (iii) Participant shall have provided the
Company with written assurances, in form and substance satisfactory to counsel of the Company, that (i) the proposed disposition does not require registration of the Shares under the Securities Act, or (ii) all appropriate action necessary
for compliance with the registration requirements of the Securities Act or of any exemption from registration available under the Securities Act (including Rule 144) has been taken; and 

(iv) Company shall have elected not to exercise its Right of First Refusal provided in its Bylaws. 

(c) Transferee Obligations. Each person (other than the Company) to whom the Shares (or any portion thereof) are transferred must,
as a condition precedent to the validity of such transfer, acknowledge in writing to the Company that such person is bound by the provisions of this Agreement and that the transferred Shares are subject to (a) the Company’s Right of First
Refusal provided in its Bylaws and (b) the lock-up provisions of Section 6 below, to the same extent such Shares would be so subject if retained by the Participant. 

 

	 	4.	RESTRICTIVE LEGENDS 

 All
certificates representing the Shares shall have endorsed thereon legends in substantially the following forms (in addition to any other legend which may be required by other agreements between the parties hereto): 

(a) “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE
SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. HOLDER SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF
THE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAW.” 

(b) “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL OPTION IN FAVOR OF THE COMPANY AND/OR
ITS ASSIGNEE(S), AS PROVIDED IN THE BYLAWS OF THE COMPANY.” 

  
 2 

 (c) “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE, INCLUDING A LOCKUP PERIOD OF UP TO 180 DAYS IN THE EVENT OF A PUBLIC OFFERING.” 
 (d)
Any legend required by appropriate state securities law. 
  

	 	5.	INVESTMENT REPRESENTATIONS 

In connection with the grant of the Shares, Participant represents to the Company the following: 

(a) Participant is aware of the Company’s business affairs and financial condition and has acquired sufficient information
about the Company to reach an informed and knowledgeable decision to acquire the Shares. Participant is acquiring the Shares for investment for Participant’s own account only and not with a view to, or for resale in connection with, any
“distribution” thereof within the meaning of the Securities Act. Participant has no present intention of selling or otherwise disposing of all or any portion of the Shares and no one other than Participant has any beneficial ownership of
any of the Shares. 
 (b) Participant understands that the Shares have not been registered under the Securities Act by
reason of a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant’s investment intent as expressed herein. 
 (c) Participant further acknowledges and understands that the Shares must be held indefinitely unless the Shares are subsequently registered under the Securities Act or an exemption from such
registration is available. Participant further acknowledges and understands that the Company is under no obligation to register the Shares. Participant understands that the certificate evidencing the Shares will be imprinted with a legend that
prohibits the transfer of the Shares unless the Shares are registered or such registration is not required in the opinion of counsel for the Company. 
 (d) Participant is familiar with the provisions of Rules 144 and 701, under the Securities Act, as in effect from time to time (“Rule 144” and “Rule 701” respectively), which,
in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly, from the issuer thereof (or from an affiliate of such issuer), in a non-public offering subject to the satisfaction of certain
conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time of issuance of the securities, such issuance will be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting
requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the securities exempt under Rule 701 may be sold by Participant ninety (90) days thereafter, subject to the satisfaction of certain of the conditions specified by
Rule 144 and the Lock Up Period provision described below. 
 (e) In the event that the issuance of the Shares does not
qualify under Rule 701 at the time of grant, then the Shares may be resold by Participant in certain limited circumstances subject to the provisions of Rule 144, which requires, among other things: (i) the availability of certain public
information about the Company and (ii) the resale occurring following the required holding period under Rule 144 after the Participant has been granted, and full vesting of, the securities to be sold. 

  
 3 

 (f) Participant further understands that at the time Participant wishes to sell the
Shares there may be no public market upon which to make such a sale, and that, even if such a public market then exists, the Company may not be satisfying the current public current information requirements of Rule 144 or 701, and that, in such
event, Participant would be precluded from selling the Shares under Rule 144 or 701 even if the minimum holding period requirement had been satisfied. 
 (g) Participant further warrants and represents that Participant has either (i) preexisting personal or business relationships, with the Company or any of its officers, directors or
controlling persons, or (ii) the capacity to protect his own interests in connection with the grant of the Shares by virtue of the business or financial expertise of the Participant or of professional advisors to Participant who are
unaffiliated with and who are not compensated by the Company or any of its affiliates, directly or indirectly. By reason of Participant’s business or financial experience, Participant is capable of evaluating the merits and risks of this
investment, has the ability to protect Participant’s own interests in this transaction and is financially capable of bearing a total loss of this investment. 
  

	 	6.	LOCK-UP 

 Participant
hereby agrees, if so requested by the Company or the managing underwriters in connection with the Company’s initial public offering, that without the prior written consent of the Company or the managing underwriters, as the case may be, the
Participant will not sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of the Shares (other than those included in the registration) for such period of time (not to exceed one hundred eighty
(180) days) from the effective date of such registration as may be requested by the underwriters; provided, however, that such one hundred eighty (180) day period may be extended to the extent necessary to permit any managing underwriter
to comply with FINRA Rule 2711(f)(4) or similar rule. 
  

	 	7.	REFUSAL TO TRANSFER 

 The
Company shall not be required (a) to transfer on its books any Shares which shall have been transferred in violation of any of the provisions set forth in this Agreement or (b) to treat as owner of such Shares or to accord the right to
vote as such owner or to pay dividends to any transferee to whom such Shares shall have been so transferred. Participant agrees that, to effect compliance with the restrictions imposed by this Agreement, the Company may issue appropriate
“stop-transfer” instructions to its transfer agent, if any, and if the Company transfers its own securities, it may make appropriate notations to the same effect in its records. 

 

	 	8.	TAXES AND TAX CONSEQUENCES 

PARTICIPANT SHALL BE LIABLE FOR ANY AND ALL TAXES, INCLUDING BUT NOT LIMITED TO, WITHHOLDING TAXES, ARISING OUT OF THIS GRANT. PARTICIPANT
FURTHER UNDERSTANDS THAT PARTICIPANT MAY SUFFER ADVERSE TAX CONSEQUENCES AS A RESULT OF PARTICIPANT’S ACQUISITION OR DISPOSITION OF THE SHARES. PARTICIPANT REPRESENTS THAT PARTICIPANT HAS CONSULTED WITH ANY TAX ADVISER PARTICIPANT DEEMS
ADVISABLE IN 

  
 4 

 
CONNECTION WITH THE ACQUISITION OR DISPOSITION OF THE SHARES AND THAT PARTICIPANT IS NOT RELYING ON THE COMPANY FOR ANY TAX ADVICE. 

 

	 	9.	NO CONTRACTUAL RIGHTS 

PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE TRANSACTIONS CONTEMPLATED HEREUNDER DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF
CONTINUED ENGAGEMENT AS A CONSULTANT OR EMPLOYEE OF THE COMPANY, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE WITH PARTICIPANT’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE PARTICIPANT’S CONSULTING RELATIONSHIP OR EMPLOYMENT AT
ANY TIME WITH OR WITHOUT CAUSE. 
  

	 	10.	MISCELLANEOUS 

 (a)
Notices. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed facsimile if sent during normal business
hours of the recipient, and if not during normal business hours of the recipient, then on the next business day, (c) five (5) calendar days after having been sent by registered or certified mail, return receipt requested, postage prepaid,
or (d) one (1) business day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the other party hereto at such party’s
address hereinafter set forth on the signature page hereof, or at such other address as such party may designate by ten (10) days advance written notice to the other party hereto. 

(b) Successors and Assigns. This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to
the restrictions on transfer herein set forth, be binding upon Participant, Participant’s successors, and assigns. 

(c) Governing Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of
California. The parties agree that any action brought by either party to interpret or enforce any provision of this Agreement shall be brought in, and each party agrees to, and does hereby, submit to the jurisdiction and venue of, the appropriate
state or federal court for the district encompassing the Company’s principal place of business. 
 (d) Further
Execution. The parties agree to take all such further action(s) as may reasonably be necessary to carry out and consummate this Agreement as soon as practicable, and to take whatever steps may be necessary to obtain any governmental approval in
connection with or otherwise qualify the issuance of the securities that are the subject of this Agreement. 
 (e) Entire
Agreement; Amendment. This Agreement and any attachments hereto constitute the entire agreement between the parties with respect to the subject matter hereof and supersede and merge all prior agreements or understandings, whether written or
oral. This Agreement may not be amended, modified or revoked, in whole or in part, except by an agreement in writing signed by each of the parties hereto. 

  
 5 

 (f) Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be
excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and be enforceable in accordance with its terms. 

(g) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of
which together shall constitute one instrument. 

*        *        * 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
Effective Date. 
  

			
	SOLAZYME, INC.
		
	By:	 	
 

			
		 	Tyler Painter

			
		
	Title:	 	Chief Financial Officer

			
	Address:	 	   225 Gateway Boulevard
   South San Francisco, CA 94080

	
	PARTICIPANT
	
	  

	Name	 	
		
	Address:	 	  

		 	  

 ATTACHMENTS: 
  

			
	Exhibit A	  	Spousal Consent

  
 7 

 EXHIBIT A 
 Spousal Consent 
 The undersigned spouse of Participant has read,
understands, and hereby approves the Restricted Stock Agreement between Participant and the Company (the “Agreement”). In consideration of the Company’s granting Participant the Shares as set forth in the Agreement, the
undersigned hereby agrees to be irrevocably bound by the Agreement and further agrees that any community property interest and any other interest shall similarly be bound by and subordinate to the requirements of the Agreement. The undersigned
hereby appoints Participant as attorney-in-fact with respect to any amendment or exercise of any rights under the Agreement, and the undersigned hereby agrees that the Company and the other shareholders of the Company need not seek any further
consent from the undersigned and may deal solely with Participant in connection with all matters under the Agreement. 
  

 

			
	  

	Participant’s Spouse:
		
	Address:	 	  

		
		 	  

 EXHIBIT A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]